News and Announcements
Proteomics International Receives FY16 R&D Tax Incentive
- Published September 23, 2016 11:51AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st September 2016, ASX Announcement
Innovative biomarker research conducted by Proteomics International Laboratories Ltd (PILL, ASX: PIQ) has been boosted by the receipt of more than half a million dollars in research and development tax incentive for the 2015-16 financial year.
PILL’s sustainable business model sees the company use revenue generated from analytical services to fun pioneering research into next generation diagnostic tests and drug delivery.
This self-sustaining model adopted blue sky concepts with cash flow from day one, using revenue from services to cover operational costs and drive substantial investment in R&D.
To view the full announcement, please click on the button below.